Transactions

  • 1
  • 2

NOTEWORTHY

  • 1
  • 2
  • 3

Avalon Managing Director Elected to the Board of Directors of NYSSA

New York (PRWEB)

Lynda Davey, CEO of Avalon Group, Ltd., is proud to announce that Karen Sterling, Ph.D., CFA, Avalon’s Managing Director of Health Care Investment Banking, has been elected to the Board of Directors of the New York Society of Security Analysts (NYSSA).

Founded in 1937 by financial industry pioneers including Benjamin Graham, NYSSA is a non-profit organization of financial professionals dedicated to continued excellence in finance education, and promoting the highest standards of ethical conduct and professional practices in the field. NYSSA currently has nearly 10,000 members, and is the largest and most active of over 140 local societies worldwide that comprise the CFA Institute, issuer of the Chartered Financial Analyst designation. The CFA Institute has over 90,000 members.

Commenting on the election of Dr. Sterling and other new members of NYSSA’s board, Society president Nancy Morris, CFA, said, "Their experience and proven business leadership will undoubtedly serve our Society well." Avalon Group’s CEO, Lynda Davey, said Karen’s experience as both a true scientist and a successful investment banker brings a unique skill set to assist the development of the NYSSA. This expertise allows her to understand our clients and translate their expertise in the capital markets.

At Avalon Group, Dr. Sterling offers investment banking services including strategic advice, private and public placement to companies in the biotechnology, pharmaceutical, medical devices, healthcare services, and healthcare IT sectors. Prior to founding the health care investment banking division at Avalon in 2009, she was vice president and senior analyst at Fridson Investment Advisors, an investment management firm specializing in corporate credit opportunities and previously was quantitative and fundamental analyst at Martin Fridson’s FridsonVision. Additionally, until 2009, she published equity research reports and financial analysis of life sciences companies through Karen Sterling Bio-Pharma Insight. Dr. Sterling is widely published in peer-reviewed journals of both finance and science.

In addition to being awarded the CFA designation in 2006, Dr. Sterling earned two Master’s degrees and a Ph.D. in biochemistry and molecular biophysics from Columbia University. In 2005, while deployed to Antarctica as a research scuba diver on an NSF-funded project, she became the only financial analyst in history to update her equity research coverage via satellite from a remote field camp on the Antarctic continent.

Avalon Group, Ltd. Is a leading, boutique investment bank and strategic advisory firm, Avalon Group, Ltd. provides clients the quality and technical expertise of a major investment bank while maintaining the confidential personal service and efficiency of a boutique firm. Avalon’s services include arranging private investments, registered direct offerings, and PIPEs; as well as providing fairness opinions, mergers and acquisitions, restructuring, and strategic advisory services. Since 1992, Avalon has worked with high caliber, committed corporate leaders to expand their businesses, re-capitalize or re-organize firms, sell or purchase divisions, and arrange liquidity events. Our clients have ranged from mid-market, private companies and Fortune 500 companies to multi-national entities and early stage ventures.